Emami Limited Secures 'IND AA+/Stable/IND A1+' Rating for INR 1,800 Million Bank Loan Facilities
India Ratings and Research (Ind-Ra) has assigned a 'IND AA+/Stable/IND A1+' rating to Emami Limited's INR 1,800 million bank loan facilities. The rating reflects Emami's robust financial health and strong market position in the FMCG sector. The company reported revenue of INR 38.10 billion and EBITDA of INR 10.30 billion in FY25, with an EBITDA margin of 26.90%. Emami maintains market leadership in several niche product categories, including Navratna Cooling Oil (68% market share) and Boro Plus Antiseptic Cream (60% market share). The company's strengths include a diverse product portfolio, strong R&D focus, and extensive distribution network. Emami also maintains a net cash position of INR 6.30 billion and a gross interest coverage of 110x in FY25. However, the company faces challenges such as intense competition and exposure to raw material cost fluctuations.

*this image is generated using AI for illustrative purposes only.
India Ratings and Research (Ind-Ra) has assigned a strong credit rating to Emami Limited 's bank loan facilities, reflecting the company's robust financial health and market position in the FMCG sector.
Credit Rating Details
| Instrument Type | Size of Issue (INR million) | Rating Assigned | Rating Action |
|---|---|---|---|
| Bank loan facilities | 1,800 | IND AA+/Stable/IND A1+ | Assigned |
Key Financial Highlights
- Revenue: INR 38.10 billion in FY25 (up from INR 35.80 billion in FY24)
- EBITDA: INR 10.30 billion in FY25 (increased from INR 9.50 billion in FY24)
- EBITDA Margin: 26.90% in FY25 (slight improvement from 26.50% in FY24)
- Interest Coverage: 110x in FY25 (up from 95x in FY24)
- Net Leverage: Maintained net cash position
Market Leadership
Emami continues to dominate several niche product categories:
| Product | Market Share (FY25) |
|---|---|
| Navratna (Cooling Oil) | 68.00% |
| Boro Plus (Antiseptic Cream) | 60.00% |
| Smart and Handsome (Male Grooming) | 74.00% |
| Zandu Balm & Mentho Plus (Pain Management) | 55.00% |
Business Strengths
- Strong Product Portfolio: Over 1,100 SKUs across various segments.
- R&D Focus: 137 scientists and field experts at R&D centers in Mumbai and Kolkata.
- Robust Distribution Network: Direct and indirect reach of 5.4 million outlets, with 3,400 distributors.
- International Presence: 17% of revenue from international business, spanning over 70 countries.
- Omni-channel Growth: E-commerce and modern trade contribute 23% to revenue.
Financial Position
- Net Cash Position: INR 6.30 billion at FYE25
- Gross Interest Coverage: 110x in FY25
- Working Capital Cycle: 80 days in FY25
- ROCE: 32.10% in FY25
Challenges and Risks
- Intense competition in the FMCG sector
- Exposure to raw material cost fluctuations
- High dependence on seasonal products (43% of portfolio)
- Limited increase in category penetration for some products
Emami's strong credit rating reflects its market leadership, robust financial performance, and strategic focus on niche product categories. The company's ability to maintain high margins and a net cash position, despite competitive pressures and strategic acquisitions, underscores its financial strength. However, the FMCG sector's inherent challenges and the company's exposure to seasonal products remain key areas to watch.
As Emami continues to expand its international presence and focus on strategic acquisitions, it will be crucial for the company to maintain its strong market position while navigating the evolving consumer landscape and potential economic uncertainties.
Historical Stock Returns for Emami
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.36% | -1.31% | +0.11% | -9.60% | -17.16% | +24.39% |











































